DE&I leaders, executives, and professionals from the pharma, biotech, healthcare, and allied industries, are invited to the 2nd Advancing Diversity Equity & Inclusion (“ADEI”) In Pharma and Healthcare Summit. This online live-streaming event will be held on December 8-9, 2022. The agenda will guide you to move from awareness towards advocacy and action, as you build a culture of representation and inclusion for success in the workplace and clinical trial management.
Professionals and industry experts from the medical realm gather on this forum to discuss and explore ways to attain success and improve the patient’s overall experience. This live-streaming event is attended by dignitaries and medical professionals from all over the world. They share valuable insights, get the know-how of trending healthcare issues, and analyze strategies for improved drug R&D, disease awareness, and clinical trial outcomes.
The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing b2b events. The global event company strives to meet the dynamic informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries.
Topics being covered at the summit include:
- Build workplace cultures that support different types of people, including LGBTQ
- Work towards the inclusion of disability and neurodiversity in the workplace
- Ensure better DE&I in clinical trials and drug development
- Discuss the best yardstick to measure the scope and durability of change
- Implement a recruiting strategy that aligns with your organization’s goals
- Explore the hurdles of incorporating DE&I in medical research and publishing
- What is the status of ERGs/BRGs in driving a culture of inclusion?
- Discuss the importance of creating a sense of belonging to the different facets of the society
- Initiate employee well-being programs that protect your initiatives and gains
This summit strongly emphasizes the need for inclusivity, belonging, and equality, and demonstrates how these factors positively impact drug R&D, disease awareness, and clinical trial outcomes. There will also be a highlight case study where Pfizer will share insights on the five-point strategy the organization implemented to successfully close the gender gap and reinforce equitable gender distribution.
To learn more, please visit https://nnw.fm/bNQrd.
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 50+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
No comments:
Post a Comment